Tag : M.P.H.


Hodgkin lymphoma study shows prospect of long-term benefits of proton therapy

Smaller amounts of spillover radiation to healthy tissue and organs have heightened interest in using protons to treat Hodgkin lymphoma.   In the first-of-its-kind study, prospectively comparing radiation dose to normal tissue for involved-node proton therapy with three-dimensional conformal radiation therapy (3DCRT) and intensity modulated radiation therapy (IMRT) in Hodgkin lymphoma patients, the mean dose of inadvertent proton radiation of healthy tissue was about 50 percent less than the mean dose of spillover radiation from 3DCRT and IMRT.   Radiation oncologists call spillover radiation to healthy areas of the body that occur during photon and proton radiation treatments the “integral dose.”   “With proton therapy reducing the integral dose... Full article